Keep on loading up while the opportunity still exists.
According to a blog posting today from Greg Ellis, a senior healthcare analyst for The MichaelBass Group, "After following MMRGlobal for the last 3 years our research has concluded that OTC: MMRF is one of the most undervalued health care IT plays we've seen in recent years."